At IDWeek 2026, IDSA and HIVMA leaders and clinician advocates outline how stories, relationships, and bipartisan outreach shape ID and HIV policy.
|Articles|December 11, 2012
When A Plan Overpays For A Service, Is A Patient Responsible For A Refund?
Advertisement
It's been more than three years since Lisa Dowden had gastric bypass surgery. As the operation has receded into her medical history, however, her insurer has renewed its interest.
In September, Dowden, a 51-year-old partner at a law firm in the District, received a letter informing her that her health plan had overpaid by more than $9,000 what it owed for the services of the assistant surgeon in her operation. Dowden, the letter said, is responsible for paying it back.
Read the full story:
Source: Kaiser Health News
Advertisement
Related to this article
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease.
Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates.
Jennifer Flythe, MD, MPH, discusses individualizing dialysis volume management and why guideline-directed therapy use lags in advanced CKD.
Povetacicept reduced proteinuria by 52% vs 4.3% with placebo at week 36 in adults with IgA nephropathy in the phase 3 RAINIER trial’s interim analysis.
Outpatient dialysis for unfunded patients with ESKD cut ED reliance and costs, while church-based CKD screening improved blood pressure.
Asian expert consensus updates mantle cell lymphoma treatment guidelines, highlighting uneven BTK inhibitor, ibrutinib and CAR T-cell access across Asia.
At ASN Kidney Week 2026, nephrologists said value-based kidney models improved dialysis starts, but payment cuts and MA growth are pushing practices out.
Advertisement
Advertisement
Trending on AJMC
1
Former USAID Health Chief Says Aid Cuts Are Costing Children's Lives
2
IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness
3
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
4
It’s the Best of Times and Worst of Times for Cancer Care in Tampa
5